InvestSMART

Micro-X Limited (ASX: MX1) - Announcements

Current share price for MX1 : $0.041 0.007 (14.58%)+

ASX company news and announcements for Micro-X Limited (MX1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Micro-X Limited (MX1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Micro-X Limited (MX1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Micro-X Limited (MX1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 MX1 - Company Presentation 29 Jul 2021 8:26AM $0.300 $0.041 fallen by 86.33%
$31 MX1 - Quarterly Cash Flows and Activities Statement 28 Jul 2021 8:31AM $0.305 $0.041 fallen by 86.56%
$31 MX1 - Successful testing of high voltage generator 21 Jul 2021 8:46AM $0.310 $0.041 fallen by 86.77%
$31 MX1 - Rover enters Veterinary Market 1 Jul 2021 9:31AM $0.320 $0.041 fallen by 87.19%
$31 MX1 - Rover EMEA Distribution and Arab Health conference 22 Jun 2021 9:45AM $0.315 $0.041 fallen by 86.98%
$31 MX1 - Seattle office opening 31 May 2021 9:06AM $0.340 $0.041 fallen by 87.94%
$31 MX1 - Rover FDA approval opens US Healthcare Market 26 May 2021 8:23AM $0.320 $0.041 fallen by 87.19%
$31 MX1 - Presenting at AusMed Tech Conference 17 May 2021 8:37AM $0.340 $0.041 fallen by 87.94%
$31 Becoming a substantial holder 10 May 2021 4:20PM $0.325 $0.041 fallen by 87.38%
$31 MX1 - Repays SAFA Facility and Debt Free 30 Apr 2021 12:11PM $0.340 $0.041 fallen by 87.94%
$31 MX1 - IED Camera at Robotics Expo 21 Apr 2021 9:26AM $0.330 $0.041 fallen by 87.58%
$31 MX1 - Presenting at Goldman Sachs Healthcare Forum 20 Apr 2021 8:26AM $0.335 $0.041 fallen by 87.76%
$31 MX1 Quarterly Cash Flows and Activity Statement 13 Apr 2021 8:16AM $0.350 $0.041 fallen by 88.29%
$31 MX1 - Presentation to Evans and Partners Conference 24 Mar 2021 8:25AM $0.320 $0.041 fallen by 87.19%
$31 MX1 - Market Update - Thales Settlement and IED X-ray camera 16 Mar 2021 9:31AM $0.345 $0.041 fallen by 88.12%
$31 MX1 - ASX Conference Presentation 15 Mar 2021 11:05AM $0.335 $0.041 fallen by 87.76%
$31 MX1 - Change in Director's interest - Y.King 10 Mar 2021 2:20PM $0.360 $0.041 fallen by 88.61%
$31 MX1 - Cleansing Statement 10 Mar 2021 2:20PM $0.360 $0.041 fallen by 88.61%
$31 MX1 - Appendix 2A 10 Mar 2021 2:18PM $0.360 $0.041 fallen by 88.61%
$31 Micro X - Cleansing Statement 5 Mar 2021 2:00PM $0.375 $0.041 fallen by 89.07%
$31 Change of Director's Interest Notice - Alexander Gosling 5 Mar 2021 1:55PM $0.375 $0.041 fallen by 89.07%
$31 Change of Director's Interest Notice - Jim McDowell 5 Mar 2021 1:55PM $0.375 $0.041 fallen by 89.07%
$31 MX1 - Appendix 2A 5 Mar 2021 1:53PM $0.375 $0.041 fallen by 89.07%
$31 MX1 - Successful MRFF Funding Award 1 Mar 2021 8:55AM $0.375 $0.041 fallen by 89.07%
$31 Change of Director's Interest Notice - Yasmin King 26 Feb 2021 3:17PM $0.375 $0.041 fallen by 89.07%

376 - 400 of 707 results

Page 16 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.